Phase II, observer-blind follow-up study to assess reacto-and immunogenicity of GSK Biologicals' pneumococcal conjugate vaccine (GSK1024850A), when given as booster in primed children or as 2-dose catch-up in unprimed children.
Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed)
Infections, Streptococcal
Phase 2
An annotated case report form is not available for this study. A blank case report form will be provided.
May 2013